July 2, 2016 by lowes1

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

Condition: Asthma
Interventions: Biological: Benralizumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified June 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Leave a Reply